KR20140051543A - Method for producing fermented herb extract with high gaba content using lactobacillus plantarum k154 - Google Patents
Method for producing fermented herb extract with high gaba content using lactobacillus plantarum k154 Download PDFInfo
- Publication number
- KR20140051543A KR20140051543A KR1020120117656A KR20120117656A KR20140051543A KR 20140051543 A KR20140051543 A KR 20140051543A KR 1020120117656 A KR1020120117656 A KR 1020120117656A KR 20120117656 A KR20120117656 A KR 20120117656A KR 20140051543 A KR20140051543 A KR 20140051543A
- Authority
- KR
- South Korea
- Prior art keywords
- lactobacillus plantarum
- gaba
- starter
- plant extract
- extract
- Prior art date
Links
- 240000006024 Lactobacillus plantarum Species 0.000 title claims abstract description 24
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title claims abstract description 23
- 229940072205 lactobacillus plantarum Drugs 0.000 title claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 16
- 239000000284 extract Substances 0.000 title abstract description 10
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 108
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 54
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 54
- 239000000419 plant extract Substances 0.000 claims abstract description 18
- 239000007858 starting material Substances 0.000 claims abstract description 18
- 235000013923 monosodium glutamate Nutrition 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 7
- 239000008103 glucose Substances 0.000 claims abstract description 6
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 5
- 239000012138 yeast extract Substances 0.000 claims abstract description 5
- 238000000855 fermentation Methods 0.000 claims description 17
- 230000004151 fermentation Effects 0.000 claims description 17
- 239000002609 medium Substances 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 12
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 11
- 239000004223 monosodium glutamate Substances 0.000 description 11
- 239000004310 lactic acid Substances 0.000 description 6
- 235000014655 lactic acid Nutrition 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 241000186660 Lactobacillus Species 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 229940039696 lactobacillus Drugs 0.000 description 4
- 239000006872 mrs medium Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 235000020510 functional beverage Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 235000021109 kimchi Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 235000021001 fermented dairy product Nutrition 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108010009004 proteose-peptone Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
Abstract
Description
본 발명은 락토바실러스 플랜타룸(Lactobacillus plantarum) K154를 이용하여 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 발효 식물 추출물 제조방법에 관한 것이다.The present invention relates to the use of Lactobacillus plantarum The present invention relates to a method for producing a fermented plant extract in which gamma-aminobutyric acid (GABA) is promoted using K154.
감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)은 억제성 신경전달물질로서 혈압상승을 억제하고 시력증진에 효과가 있으며 불안감, 초조감 등을 진정시키는 작용을 하는 것으로 알려진 물질이다. 동물의 경우 뇌, 심장, 폐, 신장 등에 분포되어 있으며, 식물의 경우 발아현미, 녹차 등에서 주로 발견되고 있다. 스트레스에 시달리는 현대인이나 수험생, 알코올 과다 섭취자의 경우 뇌와 혈중 GABA 농도가 낮은 것으로 보고되어 있으며, 체내 GABA 농도의 극심한 부족은 발작, 경련, 간질 증세를 일으키는 것으로 알려져 있다.Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter, which is known to inhibit blood pressure buildup, improve visual acuity, and calm anxiety and nervousness. In animals, it is distributed in the brain, heart, lung, kidney, etc. In the case of plants, it is mainly found in germinated brown rice and green tea. Hypnotists, examinees, and alcohol-consuming sufferers suffering from stress are reported to have low levels of GABA in the brain and blood, and a severe shortage of GABA in the body is known to cause seizures, convulsions, and epilepsy.
이러한 GABA의 기능성이 알려지면서 의약품으로서 뿐만 아니라 기능성 식품 소재로서 관심이 높아지고 있다. 현재 GABA는 현미, 녹차, 맥아, 배추 등에 자연적으로 약간 함유되어 있으나, 그 함량이 낮아 자연 식품으로 섭취하는 양으로는 생리활성을 기대하기 어렵다. 이러한 식물들의 GABA 함유량을 높이기 위해서 차잎과 보리맥아 제조시 발아된 보리의 혐기적 처리와 현미 발아시 글루탐산(glutamic acid) 첨가를 통하여 식물체 내 GABA 함량을 증가시켰다(Chang et al., 1992; Jeon et al., 2004; Park et al., 2001; Yokoyama et al., 2002). 그러나 식물을 원재료로 한 GABA의 생산에는 한계가 있으므로 GABA 대량생산을 위해 미생물을 이용한 많은 연구가 수행되고 있다. 이중 젖산균은 인간이 이용할 수 있는 가장 유익한 미생물의 한 종류로서 예로부터 발효 유제품을 중심으로 장류, 김치, 젓갈, 소시지, 의약품 등에 걸쳐 인류생활에 폭넓게 활용되어 내려오고 있다. 하지만, GABA를 생산하는 균주의 분리 및 개량에 대한 연구는 다양한 측면에서 이루어진데 반해 GABA의 함량을 높인 식품이나 기능성 음료에 관한 연구는 아직 미비한 실정이다.
As the function of GABA is known, interest as functional food materials as well as pharmaceuticals is increasing. Currently, GABA is slightly contained in brown rice, green tea, malt, and cabbage, but its content is low and it is difficult to expect physiological activity by the amount of natural food. In order to increase the GABA content of these plants, GABA content in the plant was increased by anaerobic treatment of barley germinated in the preparation of tea leaves and barley malt, and glutamic acid addition during brown germination (Chang et al., 1992; Park et al., 2001; Yokoyama et al., 2002). However, since there is a limit to the production of GABA using plant-based materials, many studies using microorganisms for mass production of GABA have been conducted. Among them, lactic acid bacteria are one of the most beneficial microorganisms that can be used by human beings, and they have been used widely in fermented dairy products, such as soy sauce, kimchi, salted fish, sausages and medicines. However, studies on the isolation and improvement of strains producing GABA have been made in various aspects, but studies on foods or functional beverages having increased contents of GABA have not been studied yet.
한편, 한국등록특허 제0404921호에서는 건망증 개선 효능이 있는 총명차의 제조방법을 개시하고 있으나, 이는 원지, 감초 등의 한방 생약재가 혼합된 총명차로서 젖산균을 이용한 발효나 GABA에 대한 언급이 없다. 따라서, 본 발명자들은 총명탕의 주요 약재로 사용되는 석창포, 원지 및 복령 추출물의 젖산 발효를 통해 GABA 함량을 증진시킨 발효 식물 추출물을 제조하여 본 발명을 완성하였다.On the other hand, Korean Patent No. 0404921 discloses a preparation method of tea ginseng which has ameliorating effect for forgetfulness, but it is not mentioned about fermentation using lactic acid bacteria or GABA as a total ginseng mixed with oriental herb medicine such as Japanese papaya and licorice. Accordingly, the present inventors have completed the present invention by preparing a fermented plant extract having enhanced GABA content through lactic acid fermentation of extracts of Seokchangpo, native and ginseng extracts, which are used as main medicaments of Gomyeongmang.
본 발명의 목적은 젖산균인 락토바실러스 플랜타룸(Lactobacillus plantarum) K154 스타터를 이용하여 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 발효 식물 추출물 제조방법을 제공하는 데에 있다.It is an object of the present invention to provide a method for producing a fermented plant extract in which gamma-aminobutyric acid (GABA) is promoted using Lactobacillus plantarum K154 starter, which is a lactic acid bacterium.
본 발명의 다른 목적은 상기의 방법에 의해 제조된 GABA가 증진된 발효 식물 추출물을 제공하는 데에 있다.Another object of the present invention is to provide a GABA-enhanced fermented plant extract prepared by the above method.
상기 목적을 달성하기 위하여, 본 발명은 배지에서 락토바실러스 플랜타룸(Lactobacillus plantarum)을 배양하여 스타터(starter)를 준비하는 단계; 상기 락토바실러스 플랜타룸 스타터를 0.1 내지 10 중량% 글루코즈(glucose) 및 0.1 내지 5 중량% 효모추출물(yeast extract)이 포함된 식물 추출물에 접종하는 단계; 및 상기 접종된 식물추출물을 발효시키는 단계를 포함하는 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 발효 식물 추출물 제조방법을 제공한다. 상세하게는, 상기 배지에는 0.1 내지 5 중량% 모노소듐 글루타메이트(mono sodium glutamate; MSG)를 더 첨가하는 것을 특징으로 한다.In order to accomplish the above object, the present invention provides a method for producing Lactobacillus plantarum plantarum ) to prepare a starter; Inoculating the Lactobacillus plantarum starter with a plant extract containing 0.1 to 10% by weight glucose and 0.1 to 5% by weight yeast extract; And a step of fermenting the inoculated plant extract, wherein the gamma-aminobutyric acid (GABA) is promoted. Specifically, the medium is supplemented with 0.1 to 5% by weight of monosodium glutamate (MSG).
본 발명에 있어서, "스타터(starter)"란 발효물을 제조하는 경우에 사용하는 미생물 배양액을 말한다. 따라서 스타터 미생물의 종류는 그 제품의 특성을 결정하게 되며 제품의 품질에 중요한 영향을 미친다. 미생물 중에서 스타터로 사용되고 있는 것은 박테리아, 곰팡이, 효모 등을 들 수 있으며, 이것을 단독 혹은 혼합하여 사용할 수 있다.In the present invention, the term "starter" refers to a culture medium of microorganisms used for producing a fermented product. Therefore, the types of starter microorganisms determine the characteristics of the product and have an important influence on the quality of the product. Bacteria, fungi, yeast, etc., which are used as starters in microorganisms, can be used alone or in combination.
상기 배지로는 락토바실러스(Lactobacillus) MRS 배지가 바람직하나, 상기 균주의 배양에 적합한 배지라면 특별히 이에 한정되는 것은 아니다. The medium is preferably a Lactobacillus MRS medium, but is not particularly limited as long as it is a medium suitable for culturing the strain.
상기 MSG의 첨가량이 0.1 중량% 이하인 경우 GABA 생성에 필요한 전구물질이 부족하게 되는 문제가 발생할 수 있고, 5.0 중량%을 초과하는 경우 GABA로 전환되지 않은 MSG가 남아 있게 되는 문제가 발생할 수 있다.
If the amount of MSG added is less than 0.1 wt%, the precursor required for GABA production may be insufficient. If the amount of MSG is more than 5.0 wt%, MSG not converted to GABA may remain.
또한 본 발명에 있어서, 상기 식물 추출물은 원지, 백복령 및 석창포를 1:1:1의 중량비로 열수 추출한 것을 특징으로 하고, 상기 락토바실러스 플랜타룸은 락토바실러스 플랜타룸(Lactobacillus plantarum) K154(KACC91727P)인 것을 특징으로 한다. In the present invention, the plant extract is characterized by extracting raw paper, Baekbokryeong and Seokchangpo at a weight ratio of 1: 1: 1, wherein the Lactobacillus plantarum is Lactobacillus plantarum plantarum ) K154 (KACC91727P).
본 발명에 있어서, "총명탕"은 백복신, 원지, 감초 및 석창포의 4가지 천연 생약재로 구성된 한약조성물로서 동의보감에는 '치다망구복능일송천언'(治多忘久服能日誦千言)라 하여 '잘 잊어버리는 것을 치료하고 오랫동안 먹으면 능히 하루에 천가지 말을 외우게 된다.'라고 기록되어 있다(출처:네이버 백과사전). 본 발명에서는 원지 300g, 백복령 300g, 석창포 300g을 물 13,000mL와 함께 약탕기에 넣고 120℃에서 총 3시간을 가열하여 식물추출물 또는 총명탕을 제조하였다.
In the present invention, "Sungmyunggang" is a herb medicine composition composed of four natural herbal medicines, such as white ginseng, lavender, liquorice, and licorice root, which is called " If you forget to forget and eat for a long time, you will be able to memorize a thousand words a day. "(Source: Naver Encyclopedia). In the present invention, 300 g of ground paper, 300 g of Baekbokryeong, and 300 g of Seokchangpo were added to a water pan with 13,000 mL of water and heated at 120 캜 for a total of 3 hours to prepare a plant extract or a common mint.
또한, 상기 접종하는 단계는 상기 락토바실러스 플랜타룸 스타터를 1 내지 10%(v/v) 접종하는 것을 특징으로 하고, 상기 발효시키는 단계는 25 내지 42℃에서 1일 내지 7일 동안 발효하는 것을 특징으로 한다.
Also, the inoculating step is characterized by inoculating 1 to 10% (v / v) of the lactobacillus plantarum starter, wherein the step of fermenting is characterized by fermentation at 25 to 42 캜 for 1 to 7 days .
상기 락토바실러스 플랜타룸 스타터의 접종량이 1 %(v/v) 이하인 경우 저농도의 균주로 인해 감마-아미노부틸산을 고함량으로 생산할 수 없고, 10 %(v/v)을 초과하는 경우 너무 빨리 발효되는 문제가 발생할 수 있다.
When the inoculum amount of the lactobacillus plantarum starter is less than 1% (v / v), it is impossible to produce gamma-aminobutyric acid in a high content due to the low concentration of the strain. When the amount exceeds 10% (v / v) There may be a problem.
또한, 본 발명은 상기의 방법에 의해 제조된 GABA가 증진된 발효 식물 추출물을 제공한다.The present invention also provides a fermented plant extract having enhanced GABA produced by the above method.
본 발명자들은 식물 추출물(석창포, 원지 및 복령 추출물)의 젖산 발효를 통해 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA) 함량을 증진시킨 발효 식물 추출물을 제조하였고, 이를 활용하여 고함량의 GABA가 포함된 기능성 음료 및 식품 개발의 가능성을 높일 수 있다.The inventors of the present invention prepared a fermented plant extract having enhanced gamma-aminobutyric acid (GABA) content through lactic acid fermentation of plant extracts (Seokchangpo, native and extract) and found that a high content of GABA It is possible to increase the possibility of developing functional beverages and foods containing them.
도 1은 MSG가 첨가된 경우(0.5%)와 첨가되지 않은 경우, 락토바실러스 플랜타룸(Lactobacillus plantarum) K66과 락토바실러스 플랜타룸(Lactobacillus plantarum) K154 균주의 GABA 생성능을 확인한 TLC 결과이다.
도 2는 발효시간에 따른 GABA 생산능을 확인한 TLC 결과이다.
도 3은 열처리 조건에 따른 GABA 생산능 변화를 확인한 TLC 결과이다.
도 4는 GABA 함량을 증진시킨 발효 식물 추출물을 제조하기 위한 발효공정도를 나타낸다.Figure 1 shows that when MSG is added (0.5%) and not added, Lactobacillus plantarum plantarum ) K66 and Lactobacillus plantarum K154 strain.
FIG. 2 shows TLC results confirming GABA production ability according to fermentation time.
FIG. 3 is a TLC result showing the change in GABA productivity according to the heat treatment conditions.
FIG. 4 shows a fermentation process diagram for preparing a fermented plant extract having enhanced GABA content.
이하, 하기 실시예를 통해 본 발명을 보다 상세하게 설명한다. 다만, 이러한 실시예에 의해 본 발명이 한정되는 것은 아니다.
Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the present invention is not limited by these examples.
< <
실시예Example
1 > 1>
GABAGABA
생성 균주의 스크리닝( Screening of the producing strains (
screeningscreening
)을 통해 )Through
GABAGABA
생산 최적화 균주 선별 Production Optimization Strain Selection
1. 균주 배양 방법1. Culture method of strain
김치에서 분리한 락토바실러스 플랜타룸(Lactobacillus plantarum) K66과 락토바실러스 플랜타룸(Lactobacillus plantarum) K154 균주는 Lactobacilli MRS agar 배지(Difco co., Ltd.)에서 단일 콜로니(colony)가 나타나게 배양한 후, MRS 배지(broth)에 모노소듐 글루타메이트(mono sodium glutamate; MSG)를 0.5% 첨가한 구와 첨가하지 않은 구로 나누어 접종한 뒤 30℃에서 24시간 동안 배양하였다.
Lactobacillus isolated from kimchi ( Lactobacillus plantarum) K66 and Lactobacillus tarum Plan (Lactobacillus plantarum ) strain K154 The cells were cultured so that a single colony appeared on Lactobacilli MRS agar medium (Difco co., Ltd.), then cultured in MRS medium broth supplemented with 0.5% monosodium glutamate (MSG) And cultured at 30 ° C for 24 hours.
2. TLC 측정방법2. TLC measurement method
샘플에 함유된 MSG 및 생성된 GABA 함량은 TLC(Silica gel 60 F254, Merck)로 확인하였다. 배양액 1mL을 speed vaccum을 이용하여 4배 농축하여 TLC plate에 2uL 점적하였다. 분석 시 전개용매로는 아세트산(acetic acid): n-부틸 알콜(n-butyl alcohol): 증류수(distilled water) (2:6:2, v/v/v)의 비율로 조제하여 4시간 이상 포화시킨 용매를 사용하였고, 발색 시약으로 0.2% 닌하이드린 용액(ninhydrin solution)을 분무하여 95℃에서 5분간 발색시켜 스팟(spot)을 확인하였다. 그 결과 락토바실러스 플랜타룸(Lactobacillus plantarum) K66 보다 락토바실러스 플랜타룸(Lactobacillus plantarum) K154 균주가 GABA 생산능이 좋았으며, MSG 첨가시 GABA 생산량이 크게 증가하는 것을 확인하였다(도 1).
The MSG contained in the sample and the produced GABA content were confirmed by TLC (Silica gel 60 F254, Merck). 1 mL of the culture was concentrated 4 times using a speed vaccum and 2 μL was added to the TLC plate. In the analysis, the developing solvent was acetic acid: n-butyl alcohol: distilled water (2: 6: 2, v / v / v) And a 0.2% ninhydrin solution was sprayed with the coloring reagent. The spot was identified by color development at 95 ° C for 5 minutes. As a result, Lactobacillus plantarum Lactobacillus tarum Plan (Lactobacillus more plantarum) K66 plantarum strain K154 exhibited a good GABA production ability, and MSG production significantly increased GABA production (FIG. 1).
< <
실시예Example
2 > 발효시간에 따른 2> Depending on fermentation time
GABAGABA
생성능Generation
확인 Confirm
발효시간에 따른 GABA 생성 최적 조건을 모색하기 위해서, 원지 300g, 백복령 300g, 석창포 300g을 물 13,000mL와 함께 약탕기에 넣고 120℃에서 총 3시간을 가열하여 미리 제조한 식물추출물을 기본배지로 하여 효모추출물(Yeast extract) 2.5%와 글루코즈(glucose) 0.5%를 첨가하여 멸균시켰다. 여기에 MRS 배지에 2% MSG를 첨가하여 30℃에서 24시간 동안 배양한 락토바실러스 플랜타룸(Lactobacillus plantarum) K154 스타터(starter)를 10%(v/v) 첨가하여 7일 동안 시간별로 발효하였다. To determine the optimal conditions for GABA production according to the fermentation time, 300 g of ground rice, 300 g of Baekbokwolgyeong and 300 g of Seokchangpo were added to a hot water tank with 13,000 mL of water and heated for 3 hours at 120 ° C for a total of 3 hours, 2.5% of yeast extract and 0.5% of glucose were added and sterilized. Then, 10% (v / v) of Lactobacillus plantarum K154 starter cultured at 30 ° C for 24 hours was added to the MRS medium with 2% MSG and fermented for 7 days.
각각 pH와 총산도(Total acidity)를 측정하였는데, pH는 각 샘플 10mL을 원심 분리한 상층액을 pH meter (Digital pH meter 420A+, Thermo Orion. Beverly, MA., USA)를 이용하여 측정하였고, 적정 산도는 상층액 10mL를 취하여 pH가 8.3에 도달할 때까지 0.1N-NaOH로 적정에 사용된 소비량을 젖산(lactic acid) 함량(%)으로 환산하여 계산하였다. 그 결과 발효가 진행될수록 pH는 증가하고 산도는 감소하여 산성화되는 경향을 나타내었다(표 2). 한편 TLC를 이용하여 GABA 함량을 알아본 결과, GABA spot은 1일째보다 3일째에서 확연히 커지며 3일 이후의 spot의 크기는 큰 차이가 없어 3일 발효 조건이 최적인 것을 확인하였다(도 2).
The pH and total acidity of each sample were measured by centrifuging each sample in 10 mL of the supernatant using a pH meter (Digital pH meter 420A +, Thermo Orion Beverly, MA, USA) The acidity was calculated by taking 10 mL of the supernatant and converting the amount used for titration with 0.1 N-NaOH to the lactic acid content (%) until the pH reached 8.3. As a result, the pH increased and the acidity decreased as the fermentation proceeded, indicating acidification (Table 2). On the other hand, GABA content was significantly increased on day 3 than on
< <
실시예Example
3 > 3>
HPLCHPLC
를 이용한 Using
GABAGABA
정량 dose
분석에 사용한 고성능 액체 크로마토그래프는 Hewlett Packard 1100 Series를 이용하였다. 컬럼은 Waters Nova-Pac C18 4μm (3.9 x 300mm)를 사용하였으며, 46℃로 유지되는 column oven에 장착하여 항온 조건에서 재현성 있게 분리되도록 하였다. 이동상은 2가지의 buffer를 이용하였다. Buffer A는 140mM NaHAc, 0.1% TEA, 6% CH3CN, pH 6.1, buffer B는 60% CH3CN을 사용하였다. 분리를 위한 gradient 조건은 표3과 같으며, 1.0mL의 유속으로 30분간 분석하였다. 검출은 UV-VIS detector (HP 1100 Series)를 사용하여 파장 254nm에서 측정하였다.
The high performance liquid chromatograph used for the analysis was a Hewlett Packard 1100 Series. The column was equipped with a Waters Nova-Pac C18 4 μm (3.9 x 300 mm) and mounted on a column oven maintained at 46 ° C to allow for reproducible separation under constant temperature conditions. Two buffers were used for mobile phase. Buffer A used 140 mM NaHAc, 0.1% TEA, 6% CH 3 CN, pH 6.1, and buffer B was 60% CH 3 CN. Gradient conditions for separation were as shown in Table 3 and analyzed at a flow rate of 1.0 mL for 30 minutes. Detection was performed at a wavelength of 254 nm using a UV-VIS detector (HP 1100 Series).
조건 별로 발효된 총명탕 중 1일에서 3일의 GABA 함량 증가 차이를 확인해보기 위해 발효총명탕에 함유된 GABA 함량을 HPLC로 분석한 결과, 발효하지 않은 총명탕에 비해 하루 발효 후 약 40배 이상, 3일 발효 뒤에는 약 60배 이상까지 GABA가 증가 되는 것을 확인하였다(표 4 및 표 5).
The GABA contents of fermented mung mungang were analyzed by HPLC to evaluate the difference in GABA content between 1 and 3 days after fermentation. After fermentation, it was confirmed that GABA was increased to about 60-fold or more (Table 4 and Table 5).
+Y.E. 2.5%+
Starter 10% (MSG 2%)
1dayHowever,
+ YE 2.5% +
Starter 10% (MSG 2%)
1day
+Y.E. 2.5%+
Starter 10% (MSG 2%)
3dayHowever,
+ YE 2.5% +
Starter 10% (MSG 2%)
3day
Starter 10% (MSG 2%)
1dayGum myeongdang + glucose 0.5% + YE 2.5% +
Starter 10% (MSG 2%)
1day
Starter 10% (MSG 2%)
3dayGum myeongdang + glucose 0.5% + YE 2.5% +
Starter 10% (MSG 2%)
3day
< <
실시예Example
4 > 발효 4> Fermentation
총명탕의Marsh
DPPHDPPH
(2,2-(2,2-
diphenyl피덴
-1--One-
picrylpicryl
--
hydrazylhydrazyl
) )
라디칼Radical
소거능 Scatters
추출물의 항산화력은 Moreno 등의 방법을 변형한 DPPH 라디칼 소거활성으로 측정하였다. 시료의 자유 라디칼(free radical) 소거활성은 안정성 라디칼(stable radical)인 DPPH에 대한 환원력을 측정한 것으로, 99% 메탄올에 각 시료를 녹여 농도 별로 희석한 희석액 800μL와 20% 메탄올에 녹인 0.15mM DPPH 용액 200μL를 가하여 30분 방치한 후 517nm에서 흡광도를 측정하였다. 각 시료 추출물의 유리 라디칼 소거활성은 시료를 첨가하지 않은 대조구의 흡광도를 1/2로 환원시키는데 필요한 시료의 농도인 RC50값으로 나타내었다(표 6). 이때 활성비교를 위하여 BHA를 사용하였다. 총명탕의 DPPH 라디컬 소거능은 높은 아니었으나, 발효가 진행되면서 높아지는 것을 확인하였다.
The antioxidant capacity of the extract was measured by DPPH radical scavenging activity modified by Moreno et al. The free radical scavenging activity of the sample was determined by measuring the reducing power against DPPH, which is a stable radical. Each sample was dissolved in 99% methanol, and 800 μL of the diluted diluted solution and 0.15 mM DPPH in 20% 200 μL of the solution was left for 30 minutes, and the absorbance was measured at 517 nm. The free radical scavenging activity of each sample extract was expressed as RC50, the concentration of the sample required to reduce the absorbance of the control without addition of the sample to ½ (Table 6). BHA was used for activity comparison. The DPPH radical scavenging ability of Sungmyung-tang was not high, but it was confirmed that it increased as the fermentation progressed.
DPPH scavenging1 ) RC 50 value (%)
DPPH scavenging 1 )
1) Concentration required for 50% reduction of DPPH at 30 min after starting the reaction. 1) Concentration required for 50% reduction of DPPH at 30 min after starting the reaction.
2) Each value is mean±S.D. (n≥3).
2) Each value is mean ± SD (n ≥ 3).
< <
실시예Example
5 > 열처리 조건에 따른 5> Depending on the heat treatment conditions
GABAGABA
함량 변화 확인 Confirmation of content change
발효총명탕을 제품화하고자 할 때 시중에 유통되기 위해서는 열처리를 해주어 잡균의 오염과 생균의 증식을 억제시켜야 한다. 따라서 가장 효율적인 조건을 찾기 위해 85℃에서 15분, 30분, 45분 시간별로 열처리를 해준 뒤, 생균수를 측정하고, TLC법을 이용하여 GABA 함량에 변화가 있는지를 관찰하였다. 생균수 측정 결과 모든 plate에서 콜로니(colony)가 나타나지 않았고, TLC결과 GABA 함량에도 차이가 없어 85℃에서 15분 동안 가열해주는 것이 최적 열처리 조건인 것을 확인하였다(도 3).When commercializing fermented mushrooms, it is necessary to heat-treat them to prevent pollution of the germs and proliferation of viable bacteria. Therefore, heat treatment was performed at 85 ° C for 15 minutes, 30 minutes, and 45 minutes to find the most efficient conditions. Then, viable cell counts were measured and it was observed whether the GABA content was changed by TLC method. As a result of counting viable cell counts, no colony appeared in all the plates, and TAB showed no difference in GABA content. It was confirmed that heating for 15 minutes at 85 ° C was the optimum heat treatment condition (FIG. 3).
Claims (7)
상기 락토바실러스 플랜타룸 스타터를 0.1 내지 10 중량% 글루코즈(glucose) 및 0.1 내지 5 중량% 효모추출물(yeast extract)이 포함된 식물 추출물에 접종하는 단계; 및
상기 접종된 식물 추출물을 발효시키는 단계를 포함하는 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 발효 식물 추출물 제조방법.Culturing Lactobacillus plantarum in a medium to prepare a starter;
Inoculating the Lactobacillus plantarum starter with a plant extract containing 0.1 to 10% by weight glucose and 0.1 to 5% by weight yeast extract; And
A method for producing a fermented plant extract having enhanced gamma-aminobutyric acid (GABA) comprising fermenting the inoculated plant extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120117656A KR101402031B1 (en) | 2012-10-23 | 2012-10-23 | Method for producing fermented herb extract with high GABA content using Lactobacillus plantarum K154 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120117656A KR101402031B1 (en) | 2012-10-23 | 2012-10-23 | Method for producing fermented herb extract with high GABA content using Lactobacillus plantarum K154 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140051543A true KR20140051543A (en) | 2014-05-02 |
KR101402031B1 KR101402031B1 (en) | 2014-06-02 |
Family
ID=50885179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120117656A KR101402031B1 (en) | 2012-10-23 | 2012-10-23 | Method for producing fermented herb extract with high GABA content using Lactobacillus plantarum K154 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101402031B1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150145764A (en) * | 2014-06-19 | 2015-12-31 | 계명대학교 산학협력단 | Method for manufacturing fermented beverage with Schisandra chinensis using GABA producing Lactobacillus |
KR20190010035A (en) * | 2017-07-20 | 2019-01-30 | 한국식품연구원 | Novel Lactobacillus plantarum K105 with Antioxidant and GABA-producing ability, composition comprising a fermented product of Dendropanax Morbifera extract using the same and manufacturing method therof |
KR20190010036A (en) * | 2017-07-20 | 2019-01-30 | 한국식품연구원 | Novel Lactobacillus plantarum K118 with Antioxidant and GABA-producing ability, composition comprising a fermented product of Dendropanax morbifera extract using the same and manufacturing method therof |
KR20210116458A (en) * | 2019-07-08 | 2021-09-27 | 오브쉐스트보 에스 오그라니체노이 오트베트스트벤노스트유 “마이” (마이 엘엘씨) | Method for Producing Rose Bay Willow Herb Beverage with High Gamma-Aminobutyric Acid Content |
CN115322940A (en) * | 2022-10-13 | 2022-11-11 | 哈尔滨美华生物技术股份有限公司 | Lactobacillus plantarum and sleep-aiding and anti-depression product and application thereof |
KR102529301B1 (en) * | 2021-12-24 | 2023-05-11 | (주)바이노텍 | A Novel Lactobacillus Plantarum BNT_G401 Strain And Its Use |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101944183B1 (en) * | 2017-06-09 | 2019-01-30 | 계명대학교 산학협력단 | Method for manufacturing yeast starter containing apple pomace and Auricularia judae by mixed fermentation with lactic acid bacteria and yeast |
KR102270890B1 (en) * | 2019-12-26 | 2021-06-29 | 경북대학교 산학협력단 | Composition of culture medium for cultivation of lactobacillus plantarum and method for producing gaba using the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100549094B1 (en) * | 2003-01-29 | 2006-02-06 | 변유량 | Novel Strains of Lactobacillus spp. and Method for Preparing ?-Aminobutyric Acid Using the Same |
ITRM20070398A1 (en) | 2007-07-17 | 2009-01-18 | Giuliani Spa | PROCEDURE FOR THE PREPARATION OF BUTIRRIC GAMMA-AMINO ACID (GABA) THROUGH LACTIC BACTERIA (LAB) ON AGRO-FOOD SURPLUS. |
-
2012
- 2012-10-23 KR KR1020120117656A patent/KR101402031B1/en active IP Right Grant
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150145764A (en) * | 2014-06-19 | 2015-12-31 | 계명대학교 산학협력단 | Method for manufacturing fermented beverage with Schisandra chinensis using GABA producing Lactobacillus |
KR20190010035A (en) * | 2017-07-20 | 2019-01-30 | 한국식품연구원 | Novel Lactobacillus plantarum K105 with Antioxidant and GABA-producing ability, composition comprising a fermented product of Dendropanax Morbifera extract using the same and manufacturing method therof |
KR20190010036A (en) * | 2017-07-20 | 2019-01-30 | 한국식품연구원 | Novel Lactobacillus plantarum K118 with Antioxidant and GABA-producing ability, composition comprising a fermented product of Dendropanax morbifera extract using the same and manufacturing method therof |
KR20210116458A (en) * | 2019-07-08 | 2021-09-27 | 오브쉐스트보 에스 오그라니체노이 오트베트스트벤노스트유 “마이” (마이 엘엘씨) | Method for Producing Rose Bay Willow Herb Beverage with High Gamma-Aminobutyric Acid Content |
KR102529301B1 (en) * | 2021-12-24 | 2023-05-11 | (주)바이노텍 | A Novel Lactobacillus Plantarum BNT_G401 Strain And Its Use |
WO2023120896A1 (en) * | 2021-12-24 | 2023-06-29 | (주) 바이노텍 | Novel lactobacillus plantarum bnt_g401 strain and use thereof |
CN115322940A (en) * | 2022-10-13 | 2022-11-11 | 哈尔滨美华生物技术股份有限公司 | Lactobacillus plantarum and sleep-aiding and anti-depression product and application thereof |
Also Published As
Publication number | Publication date |
---|---|
KR101402031B1 (en) | 2014-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101402031B1 (en) | Method for producing fermented herb extract with high GABA content using Lactobacillus plantarum K154 | |
KR100919213B1 (en) | Function-related fermentation raw materials using the composition which mixed chlorella in Rubus coreanus and Method to produce thereof | |
CN104404092A (en) | Conjugated linoleic acid isomer biological enrichment method | |
KR101786938B1 (en) | Bacillus subtilis strain SY07 isolated from traditionally fermented soybean product and uses thereof | |
CN104480150A (en) | Biological enrichment method of conjugated linolenic acid isomer | |
KR101616187B1 (en) | Method for manufacturing fermented beverage with Schisandra chinensis using GABA producing Lactobacillus | |
JP6955808B1 (en) | How to make fermented honey | |
KR20130050554A (en) | Manufacture of fermented schizandrae extract having gaba | |
KR101091833B1 (en) | Methods for preparing high quantity of S-allyl-L-cysteine to fermented products of garlic using lactic acid bacteria | |
CN111329034B (en) | Method for improving soy sauce quality | |
KR101407231B1 (en) | Method for producing fermented herb extract with high GABA content using Lactobacillus helveticus RMK85 | |
KR101846713B1 (en) | A method of preparing fermented laminaria japonica having anti-inflammatory | |
KR102011133B1 (en) | Lactobacillus plantarum MBE/L2990 strain having excellent alpha-rhamnosidase activity and bioconversion activity from ginsenoside Re and Rb1 to ginsenoside Rg1 and Rg5 | |
CN114246310B (en) | Direct-feeding type probiotics fermented millet peppery and preparation method thereof | |
KR101894423B1 (en) | Method for cultivation of mushrooms containing l-carnithine using l-carnithine containing fermentation products and the cultivated functional mushrooms containing l-carnithine | |
KR20140045790A (en) | Method for preparing makgeolli using monascus sp. and makgeolli prepared thereby | |
KR101501827B1 (en) | Method for manufacturing base of watery radish kimchi using GABA producing Lactobacillus and Opuntia humifusa | |
KR102088696B1 (en) | Saccharomyces cerevisae BA34 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof | |
KR102007569B1 (en) | Fermentation product of seomae mugwort with high palatability and functionality, and method for preparing the same | |
KR100963133B1 (en) | Function-related fermentation food using the composition which mixed chlorella in Rubus coreanus and method to produce thereof | |
Lee et al. | Chemistry of The Korean Traditional Alcoholic Beverage Makgeolli | |
KR101842196B1 (en) | Functional makgeolli and method for preparation thereof | |
KR101884999B1 (en) | Manufacturing method of Dendropanax morbifera fermentation product having antioxidant function using Lactobacillus sp. | |
JP7329221B2 (en) | Saccharopolyspora composition and its use in food | |
KR102115979B1 (en) | Antioxidant functional edible flower vinegar made from fermented solution of edible flowers by lactic acid bacteria and the preparation method of the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20170516 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20180528 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20190626 Year of fee payment: 6 |